XUNCE Shares Surge Over 16% in Session, May ARR Revenue Jumps 320% Month-on-Month Following Framework Agreement with Beijing Data Exchange

Stock News07-02 11:24

Shares of XUNCE (03317) surged more than 16% during the trading session. At the time of writing, the stock was up 8.54% to HK$132.2, with a turnover of HK$476 million.

On the evening of June 29th, XUNCE Technology signed a cooperation framework agreement with the Beijing Data Exchange. This collaboration signifies a further deepening of the company's strategic positioning within the data element market and its engagement with a national-level data trading platform. It represents a crucial step for the company in implementing its data tokenization capabilities within vertical industries, facilitating the circulation of embodied intelligent data, providing digital assetization services, and co-building a specialized data ecosystem in the biotech and healthcare sectors.

Notably, XUNCE's Token-based Annual Recurring Revenue (ARR) for May saw a substantial month-on-month increase of 320%. The proportion of token-based paid revenue exceeded 5%, with a year-end target to raise this figure to between 20% and 30%. This shift marks a transition from a project-based model to a token consumption-based billing model. Consequently, the revenue structure is evolving from a "one-time" to a "recurring" model and moving from being "labor-driven" to being "product-driven." The significant sequential jump in ARR demonstrates that customers are willing to pay continuously for the quantifiable value of tokens, rather than simply purchasing a software package.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment